Trends in incidence and treatments of spontaneous subarachnoid hemorrhage- a 10 year hospital based study - Scorecard - MDSpire

Trends in incidence and treatments of spontaneous subarachnoid hemorrhage- a 10 year hospital based study

  • By

  • Elisabeth Ronne-Engström

  • Ljubisa Borota

  • Samuel Lenell

  • Anders Lewén

  • Ehab Mahmoud

  • Christoffer Nyberg

  • Fartein Velle

  • Per Enblad

  • April 22, 2024

  • 0 min

Share

Clinical Scorecard: A Decade-Long Hospital Study on the Incidence and Management of Spontaneous Subarachnoid Hemorrhage

At a Glance

CategoryDetail
ConditionSpontaneous subarachnoid hemorrhage (SAH) due to ruptured aneurysms
Key MechanismsRupture of cerebral aneurysms causing bleeding into the subarachnoid space; risk of rebleeding and increased intracranial pressure
Target PopulationPatients admitted with spontaneous SAH from a defined Swedish population (2012-2021)
Care SettingNeurosurgery and neurointerventional departments with neurointensive care at Uppsala University Hospital

Key Highlights

  • Rapid identification and occlusion of ruptured aneurysms is critical to prevent rebleeding.
  • Neurointervention (endovascular treatment) has become the preferred first-line treatment since 1996 due to less invasiveness and better 1-year outcomes compared to microsurgery.
  • Neurointensive care includes ventricular drainage, mechanical ventilation, nimodipine administration, and tiered management of elevated intracranial pressure.

Guideline-Based Recommendations

Diagnosis

  • Use computed tomography angiography (CTA) and/or digital subtraction angiography (DSA) to identify bleeding source.
  • Assess clinical condition using Hunt & Hess score and Reaction Level Scale-85 at admission.
  • Evaluate amount of blood on initial CT scan using Fisher scale.

Management

  • Treat ruptured aneurysms as early as possible unless patient is in terminal clinical state.
  • Prefer neurointervention for aneurysm occlusion when feasible with reasonable risk.
  • Use microsurgical clipping when endovascular treatment is unsuccessful, contraindicated, or when hematoma evacuation is needed.
  • Administer nimodipine mandatorily to prevent delayed ischemic neurologic deficits (DIND).
  • Treat DIND by increasing blood volume and pressure, and consider intraarterial nimodipine.
  • Manage high intracranial pressure with cerebrospinal fluid drainage targeting 15 mm Hg threshold.
  • Use pentobarbiturates and/or hemicraniectomy as last-tier treatments for refractory intracranial hypertension.

Monitoring & Follow-up

  • Monitor neurological status continuously using RLS-85 and Hunt & Hess scores.
  • Perform structured telephone follow-up at 1 year using Extended Glasgow Outcome Scale (GOSE) to assess functional outcome.
  • Record mortality during the first year post-SAH.

Risks

  • Risk of aneurysm rebleeding if treatment is delayed.
  • Potential complications of neurointervention include aneurysm rupture during procedure.
  • Dual anti-platelet therapy required for stent use may complicate intensive care management.

Patient & Prescribing Data

Patients with ruptured cerebral aneurysms presenting with spontaneous SAH in a Swedish tertiary care center.

Neurointervention techniques evolved from coil-only to include stents, flow diverters, and intrasaccular devices, expanding treatment options especially for complex aneurysms.

Clinical Best Practices

  • Early multidisciplinary decision-making between neurovascular surgeons and neurointerventionists to select optimal aneurysm treatment.
  • Conservative management of patients with neurological deficits prior to surgery to reduce surgical trauma and improve outcomes.
  • Continuous development and adoption of advanced neurointerventional devices to treat complex aneurysms.
  • Structured neurointensive care protocols including ventricular drainage, nimodipine use, and tiered ICP management.
  • Systematic functional outcome assessment at 1 year to guide quality improvement.

References

Original Source(s)

Related Content